PPT-Big Data in the context of the Pharmaceutical Industry

Curtis Smith November 30 2016 Big Data Panel Discussion Big Data and the Pharmaceutical Industry 2 There has been substantial change to the Pharmaceutical data environment over the last 5 years . March 27th 2014, University of Zurich . Fabienne Heimgartner, Interpharma. What. . it. . needs. . for. . one. . drug. CHF . investment. working. . hours. . experiments. scientists. drug. 1 000 000 000. version. . : . 21/09/. 2015. Growth and competitiveness of the pharmaceutical industry. www.efpia.eu. Growth & Competitiveness. Growth and competiveness - rationale. Why is the pharmaceutical industry a key asset to European competitiveness ? . GlaxoSmithKline. Health matters in a globalising world. TNCs – Transnational Corporations are companies that operate in at least two countries (and often many more).. Headquarters and research facilities tend to be located in MEDCs whilst manufacturing plants have increasingly been located in LEDCs to take advantage of cheaper labour costs. . Distraction?. Mark Birkin. Professor of Spatial Analysis and Policy,. School of Geography, University of Leeds. Director, ESRC Consumer Data Research Centre. Director, Leeds Institute for Data Analytics. The Brookings Institution • . Washington, DC. Monday, October 19. th. , 2015. Promoting the Adoption of . Advanced . Manufacturing in the Pharmaceutical Industry: the FDA . Perspective. . Promoting Continuous Manufacturing in the Pharmaceutical Sector. Presented by:. Nathan . Funk, MHA, BS. Environmental Health & Safety Officer. WakeMed Health & Hospitals. 3000 New Bern Avenue. Raleigh, NC 27610. (919) 350-8375 Office. WakeMed.org. Objectives. Human Capital Outlook Implications for Skills Development in the Pharmaceutical Sector. Johannesburg. May 27 2015. Disclaimer . Any views or opinions expressed herein are solely those of the author and do not necessarily represent those of any company. T.U. . Federation of Chemical, Glass and Ceramic. . Industries. . in Poland.. Józef Woźny- . President. National . Pharmaceutical Industry plays an important role in the Polish health & care system provides patients with affordable medicines available to treat most illnesses. . Prof.. Viswanath Pingali. Indian Institute of Management Ahmedabad. 29-03-2013. 1. Preliminaries. Please organize yourselves into groups of five, preferably not from the same background. 29-03-2013. Litiahina. . Mariia. DIPLOMA PROJECT. . The topicality of the problem is . connected with the fact that the pharmaceutical market today is one of the most promising and fastest growing markets in the economy of Ukraine.. sector. . Cécile . Macé. Department of Essential Medicines and Health Products. English Technical Briefing Seminar. 30 October 2013. Ten leading causes of inefficiency. World Health Report 2010, Chapter 4. . АК «Узфармсаноат». Pharmaceutical industry of Uzbekistan. O` z f a r m s a n o a t. www.uzpharmsanoat.uz. Manufacturers of medical devices- - . 4. 6. Manufacturers of diagnostic tools- - . Industry Introduction. Challenges & Opportunities. Industry Introduction. 2010 China’s Health Expenditure was 5.1% of the GDP. From WHO statistic yearbook and . Tengwei. 2013 semiannual summit. Abida Zameer. Harrisburg University. GRAD 699 PGMT. Agenda. Introduction and Problem Statement . Methodology . Results . Discussion. Conclusions. Special . Characterstics. of the pharmaceutical industry .